Stocks
G1 Therapeutics (GTHX) R&D US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D, bln rub | 73.3 | 76.2 | 83.3 | 83.3 | 43.7 | 29.2 | |||
| Changes by years, y/y, % | -18% | +4% | +9% | 0% | -48% | -9.2% | |||
G1 Therapeutics. R&D, bln rub
G1 Therapeutics. R&D, changes, %
G1 Therapeutics. R&D, sum by quarters, bln rub
G1 Therapeutics (GTHX) R&D US GAAP (quarter values) |
||||||||
| 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | LTM ? | |||
| R&D, bln rub | 12.0 | 8.81 | 7.38 | 7.32 | 5.74 | 29.2 | ||
| Changes by years, y/y, % | -42% | -55% | -56% | -53% | -52% | |||
| Changes by quarters, q/q, % | -22% | -27% | -16% | -1% | -22% | |||
